{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:26:46Z","timestamp":1793791606125,"version":"4.6.1"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31371399"],"award-info":[{"award-number":["31371399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803132"],"award-info":[{"award-number":["81803132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002984"],"award-info":[{"award-number":["82002984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20200119"],"award-info":[{"award-number":["BK20200119"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","award":["KFDX202201"],"award-info":[{"award-number":["KFDX202201"]}],"id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116365","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:53:08Z","timestamp":1709729588000},"page":"116365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["N6-methyladenosine (m6A) modification in hepatocellular carcinoma"],"prefix":"10.1016","volume":"173","author":[{"given":"Hehua","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyi","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-198X","authenticated-orcid":false,"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jjco\/hyaa130","article-title":"Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018","volume":"50","author":"Sharma","year":"2020","journal-title":"Jpn J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112651","article-title":"The landscape of lncRNAs in hepatocellular carcinoma: a translational perspective","volume":"13","author":"Unfried","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.116365_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fonc.2020.01105","article-title":"Mechanisms of RNA N(6)-methyladenosine in hepatocellular carcinoma: from the perspectives of etiology.","volume":"10","author":"Lu","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-018-0777-4","article-title":"Immune checkpoint therapy in liver cancer","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.biopha.2024.116365_bib9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.biopha.2024.116365_bib10","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.3390\/cancers13164237","article-title":"Epigenetic changes affecting the development of hepatocellular Carcinoma","volume":"13","author":"Wolinska","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"Pt 3","key":"10.1016\/j.biopha.2024.116365_bib11","first-page":"622","article-title":"Epigenetics in hepatocellular carcinoma","volume":"86","author":"Nagaraju","year":"2021","journal-title":"Semin Cancer Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116365_bib12","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI31457","article-title":"Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma","volume":"117","author":"Calvisi","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00428-011-1103-0","article-title":"Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC","volume":"459","author":"Quint","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.biopha.2024.116365_bib14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3389\/fcell.2020.00752","article-title":"Histone deacetylases inhibit the Snail2-Mediated EMT during metastasis of hepatocellular carcinoma cells","volume":"8","author":"Hu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116365_bib15","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3390\/cancers12102734","article-title":"Thai, et al., HDAC9 is preferentially expressed in dedifferentiated hepatocellular carcinoma cells and is involved in an anchorage-independent growth","volume":"12","author":"Kanki","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib16","first-page":"462","article-title":"Highly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway","volume":"8","author":"Gu","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116365_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109551","article-title":"miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway","volume":"120","author":"Wang","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116365_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.632976","article-title":"miR-186 inhibits liver cancer stem cells expansion via targeting PTPN11","volume":"11","author":"Yao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-020-01188-4","article-title":"The role of long noncoding RNAs in hepatocellular carcinoma","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116365_bib20","article-title":"m6A modification: a double-edged sword in tumor development","volume":"11","author":"Gao","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijbs.50003","article-title":"The emerging roles of m(6)A modification in liver carcinogenesis","volume":"17","author":"Pan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"7397","key":"10.1016\/j.biopha.2024.116365_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2024.116365_bib23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The Critical Role of RNA m(6)A Methylation in Cancer.","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2024.116365_bib24","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.60115","article-title":"N(6)-methyladenosine (m(6)A) in pancreatic cancer: Regulatory mechanisms and future direction","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41419-020-03143-z","article-title":"The role of m(6)A modification in physiology and disease.","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.biopha.2024.116365_bib26","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116365_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m(6)A Readers, Writers, and Erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116365_bib29","article-title":"The Latest Research Progress of m(6)A modification and its writers, erasers, readers in infertility: a review.","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib30","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3390\/ijms22042176","article-title":"METTL16, Methyltransferase-Like Protein 16: current insights into structure and function","volume":"22","author":"Ruszkowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2024.116365_bib31","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"van Tran","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/nar\/gkz1147","article-title":"The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA","volume":"48","author":"Pinto","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116365_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m(6)A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation.","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov."},{"issue":"7620","key":"10.1016\/j.biopha.2024.116365_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression.","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib35","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/s41467-021-23892-5","article-title":"Hakai is required for stabilization of core components of the m(6)A mRNA methylation machinery","volume":"12","author":"Bawankar","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40364-021-00293-w","article-title":"Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia","volume":"9","author":"Zheng","year":"2021","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential m(6)A, m(6)A(m), and m(1)A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2024.116365_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep42271","article-title":"AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells","volume":"7","author":"Ueda","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gpb.2018.04.002","article-title":"YTH Domain: A Family of N(6)-methyladenosine (m(6)A) Readers","volume":"16","author":"Liao","year":"2018","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"7540","key":"10.1016\/j.biopha.2024.116365_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions.","volume":"518","author":"Liu","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2024.116365_bib43","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1093\/nar\/gkx141","article-title":"N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein","volume":"45","author":"Liu","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib44","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","article-title":"5' UTR m(6)A Promotes Cap-Independent Translation","volume":"163","author":"Meyer","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41422-018-0113-8","article-title":"A novel m(6)A reader Prrc2a controls oligodendroglial specification and myelination","volume":"29","author":"Wu","year":"2019","journal-title":"Cell Res"},{"issue":"22","key":"10.1016\/j.biopha.2024.116365_bib48","first-page":"3936","article-title":"Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets","volume":"27","author":"Zhang","year":"2018","journal-title":"Hum. Mol. Genet"},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/emboj.2011.392","article-title":"LRPPRC is necessary for polyadenylation and coordination of translation of mitochondrial mRNAs","volume":"31","author":"Ruzzenente","year":"2012","journal-title":"Embo J."},{"key":"10.1016\/j.biopha.2024.116365_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47261","article-title":"The Tudor SND1 protein is an m(6)A RNA reader essential for replication of Kaposi's sarcoma-associated herpesvirus","volume":"8","author":"Baquero-Perez","year":"2019","journal-title":"Elife"},{"issue":"35","key":"10.1016\/j.biopha.2024.116365_bib51","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.1808319115","article-title":"N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle","volume":"115","author":"Imam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","article-title":"Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts","volume":"16","author":"Imam","year":"2020","journal-title":"PLoS Pathog."},{"issue":"37","key":"10.1016\/j.biopha.2024.116365_bib53","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.1074\/jbc.RA120.014260","article-title":"N (6)-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling","volume":"295","author":"Kim","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.31313","article-title":"HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC","volume":"73","author":"Kim","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","article-title":"O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner.","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.116365_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib57","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N(6)-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.biopha.2024.116365_bib58","article-title":"Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib59","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41467-019-09865-9","article-title":"RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail","volume":"10","author":"Lin","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","article-title":"KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3","volume":"18","author":"Lan","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41420-021-00703-w","article-title":"RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner","volume":"7","author":"Cai","year":"2021","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib63","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2024.116365_bib64","article-title":"Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib65","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib66","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7150\/ijbs.73570","article-title":"N(6)-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis","volume":"19","author":"Zheng","year":"2023","journal-title":"Int J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1878-0261.12593","article-title":"Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras\/Raf\/ERK pathways","volume":"14","author":"Chen","year":"2020","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.116365_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153740","article-title":"The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib","volume":"92","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"issue":"13","key":"10.1016\/j.biopha.2024.116365_bib70","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.7150\/thno.42539","article-title":"SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10456-020-09744-8","article-title":"RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway","volume":"24","author":"Qiao","year":"2021","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41392-020-00299-0","article-title":"m6A RNA methylation-mediated HNF3\u03b3 reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib73","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","article-title":"N(6)-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation.","volume":"15","author":"Ma","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib74","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00204-021-03021-3","article-title":"N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization","volume":"95","author":"Liu","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2024.116365_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101085","article-title":"Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo","volume":"42","author":"Mittenb\u00fchler","year":"2020","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib76","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/hep.31222","article-title":"SIRT1 Regulates N(6) -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/21655979.2020.1787764","article-title":"The Cancer Genome Atlas (TCGA) based m(6)A methylation-related genes predict prognosis in hepatocellular carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2024.116365_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5576683","article-title":"Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response","volume":"2021","author":"Jiang","year":"2021","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","article-title":"ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1.","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-022-00370-2","article-title":"ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner","volume":"12","author":"Wang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116365_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.604766","article-title":"Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma","volume":"7","author":"Bian","year":"2020","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.biopha.2024.116365_bib82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s11658-020-00204-1","article-title":"GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation","volume":"25","author":"Ding","year":"2020","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.biopha.2024.116365_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib84","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","article-title":"YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma","volume":"18","author":"Hou","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.116365_bib85","first-page":"10","article-title":"Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation","author":"Lin","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2024.116365_bib86","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.2147\/OTT.S249527","article-title":"Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma","volume":"13","author":"Ma","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib87","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: the devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib88","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharm. Sin."},{"issue":"14","key":"10.1016\/j.biopha.2024.116365_bib89","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m\u2076A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.352","article-title":"AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation","volume":"11","author":"Bian","year":"2021","journal-title":"Clin. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wrna.100","article-title":"Evolution of SR protein and hnRNP splicing regulatory factors","volume":"3","author":"Busch","year":"2012","journal-title":"Wiley Inter. Rev. RNA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib92","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41467-021-21828-7","article-title":"RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-\u03b22","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.biopha.2024.116365_bib93","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","article-title":"YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib94","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib95","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cam4.2918","article-title":"METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma","volume":"9","author":"Lin","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib96","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","article-title":"N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4.","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib97","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/jcp.30128","article-title":"HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1\u03b1","volume":"236","author":"Yang","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"14","key":"10.1016\/j.biopha.2024.116365_bib98","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","article-title":"USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization","volume":"81","author":"Du","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib99","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13046-022-02538-4","article-title":"A functional loop between YTH domain family protein YTHDF3 mediated m(6)A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma.","volume":"41","author":"Zhou","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13046-022-02528-6","article-title":"UBR7 inhibits HCC tumorigenesis by targeting Keap1\/Nrf2\/Bach1\/HK2 and glycolysis","volume":"41","author":"Zhao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib101","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s42255-022-00622-9","article-title":"N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation","volume":"4","author":"Peng","year":"2022","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41388-020-01498-3","article-title":"Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression","volume":"40","author":"Yan","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.116365_bib103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12935-020-01520-4","article-title":"NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA","volume":"20","author":"Ding","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated Fatty Acid \u03b2-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"issue":"16","key":"10.1016\/j.biopha.2024.116365_bib105","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in Human Diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116365_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological Functions of Autophagy Genes: A Disease Perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib107","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41556-018-0235-8","article-title":"Autophagy and the cell biology of age-related disease","volume":"20","author":"Leidal","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13578-021-00661-x","article-title":"Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases","volume":"11","author":"Chen","year":"2021","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","article-title":"HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41389-018-0054-6","article-title":"Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression","volume":"7","author":"Guo","year":"2018","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib111","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib112","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-019-1105-0","article-title":"LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer","volume":"18","author":"Wang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"11-12","key":"10.1016\/j.biopha.2024.116365_bib113","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.biopha.2024.116365_bib114","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1111\/jcmm.16957","article-title":"Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11","volume":"25","author":"Fan","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.116365_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102546","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116365_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100720","article-title":"Surmounting cancer drug resistance: New insights from the perspective of N(6)-methyladenosine RNA modification","volume":"53","author":"Li","year":"2020","journal-title":"Drug Resist Updat"},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib117","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib118","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12621","article-title":"LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2\/SNAI1 complex","volume":"52","author":"Song","year":"2019","journal-title":"Cell Prolif."},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib119","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103181","article-title":"RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"Embo J."},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S2468-1253(21)00110-2","article-title":"Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial","volume":"6","author":"Vogel","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"7869","key":"10.1016\/j.biopha.2024.116365_bib121","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib122","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","article-title":"N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT\/beta-Catenin and Hippo Signaling Pathways","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116365_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib124","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3748\/wjg.v26.i2.134","article-title":"Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment","volume":"26","author":"Zhang","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","article-title":"From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cncr.29769","article-title":"Immunotherapy in hepatocellular carcinoma: Primed to make a difference?","volume":"122","author":"Harding","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib127","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-022-01558-0","article-title":"Targeting the RNA m(6)A modification for cancer immunotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib128","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib129","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med"},{"issue":"7743","key":"10.1016\/j.biopha.2024.116365_bib130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib131","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.116365_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216336","article-title":"BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy","volume":"571","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116365_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.707930","article-title":"An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment","volume":"12","author":"Du","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116365_bib134","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omtn.2020.08.004","article-title":"Crosstalk between RNA m(6)A Modification and Non-coding RNA Contributes to Cancer Growth and Progression","volume":"22","author":"Dai","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib135","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.7150\/ijbs.60641","article-title":"The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications","volume":"17","author":"Qin","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib136","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.116365_bib137","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.biopha.2024.116365_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions","volume":"17","author":"Catalanotto","year":"2016","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib139","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1568009621999210120193636","article-title":"The Impacts of Non-coding RNAs and N(6)-Methyladenosine on Cancer: Past, Present and Future","volume":"21","author":"Xu","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"issue":"7544","key":"10.1016\/j.biopha.2024.116365_bib140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarc\u00f3n","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116365_bib141","article-title":"miR-139-5p Loss-Mediated WTAP Activation Contributes to Hepatocellular Carcinoma Progression by Promoting the Epithelial to Mesenchymal Transition","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib142","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4161\/rna.24604","article-title":"On the classification of long non-coding RNAs","volume":"10","author":"Ma","year":"2013","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib143","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s43018-021-00315-4","article-title":"The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription","volume":"3","author":"Xia","year":"2022","journal-title":"Nat. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41419-022-05386-4","article-title":"ALKBH5-mediated m(6)A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116365_bib146","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2019.02.033","article-title":"A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA","volume":"450","author":"He","year":"2019","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.biopha.2024.116365_bib147","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41419-020-02967-z","article-title":"LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib148","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/hep.26537","article-title":"Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)","volume":"58","author":"Hammerle","year":"2013","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.biopha.2024.116365_bib149","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/0008-5472.CAN-23-0337","article-title":"Hypoxia-Responsive lncRNA AC115619 Encodes a Micropeptide That Suppresses m6A Modifications and Hepatocellular Carcinoma Progression","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-023-04741-8","article-title":"lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages","volume":"80","author":"Ye","year":"2023","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-023-02847-2","article-title":"LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib152","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-020-01551-9","article-title":"Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression","volume":"39","author":"Rong","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib153","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2024.116365_bib154","article-title":"N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/cr.2017.31","article-title":"Extensive translation of circular RNAs driven by N(6)-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib156","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","article-title":"The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib157","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2020.02.018","article-title":"N(6)-Methyladenosine Modification of Fatty Acid Amide Hydrolase Messenger RNA in Circular RNA STAG1-Regulated Astrocyte Dysfunction and Depressive-like Behaviors","volume":"88","author":"Huang","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116365_bib158","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2021.09.001","article-title":"m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression","volume":"26","author":"Rong","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib159","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","article-title":"N(6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating \u03b2-catenin signaling","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2024.116365_bib160","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.7150\/thno.53227","article-title":"Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116365_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-023-01108-8","article-title":"Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation","author":"Yu","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib162","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/0008-5472.CAN-21-1628","article-title":"Activation of YAP1 by N6-methyladenosine-modified CircCPSF6 Drives Malignancy in Hepatocellular Carcinoma","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib163","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.7150\/thno.32796","article-title":"Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116365_bib164","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.omtn.2020.11.009","article-title":"CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells","volume":"23","author":"Jiang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib166","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-022-01619-4","article-title":"CircGPR137B\/miR-4739\/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib167","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116365_bib168","article-title":"Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharm."},{"issue":"7860","key":"10.1016\/j.biopha.2024.116365_bib169","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111530","article-title":"METTL3 regulates m(6)A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma","volume":"41","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.biopha.2024.116365_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205148","article-title":"The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer","volume":"14","author":"Haigh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.biopha.2024.116365_bib172","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","article-title":"METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biopha.2024.116365_bib173","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 Inhibits Antitumor Immunity by Targeting m(6)A-BHLHE41-CXCL1\/CXCR2 Axis to Promote Colorectal Cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.biopha.2024.116365_bib174","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","article-title":"Chemical inhibitors targeting the oncogenic m(6)A Modifying Proteins","volume":"56","author":"Huang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.116365_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"issue":"33","key":"10.1016\/j.biopha.2024.116365_bib177","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.biopha.2024.116365_bib178","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","article-title":"Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors","volume":"6","author":"Selberg","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2024.116365_bib179","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.actbio.2021.11.041","article-title":"Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor","volume":"140","author":"Cheng","year":"2022","journal-title":"Acta Biomater."},{"issue":"15","key":"10.1016\/j.biopha.2024.116365_bib180","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1093\/nar\/gkaa653","article-title":"The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer","volume":"48","author":"Muller","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib181","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","article-title":"Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2024.116365_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.116365_bib183","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","article-title":"PLGA-Based Nanoparticles in Cancer Treatment","volume":"9","author":"Rezvantalab","year":"2018","journal-title":"Front Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116365_bib184","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biopha.2024.116365_bib185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","article-title":"ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy","volume":"165","author":"Zhai","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.116365_bib186","first-page":"57","article-title":"Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation","volume":"21","author":"Xiao","year":"2023","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.biopha.2024.116365_bib187","first-page":"6084","article-title":"m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.116365_bib188","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116365_bib189","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.116365_bib190","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/hep.26537","article-title":"Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)","volume":"58","author":"H\u00e4mmerle","year":"2013","journal-title":"Hepatology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:39:30Z","timestamp":1793788770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222400249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":190,"alternative-id":["S075333222400249X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116365","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-methyladenosine (m6A) modification in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116365"}}